| Southwest Podiatry, P.c. | |
|
5270 Alexander Rd, Dublin, VA 24084-3650 | |
| (540) 674-2444 | |
| (540) 674-2462 |
| Full Name | Southwest Podiatry, P.c. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 5270 Alexander Rd, Dublin, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770739021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 0103000769 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Southwest Podiatry, P.c. 5270 Alexander Rd, Dublin, VA 24084-3650 Ph: (540) 674-2444 | Southwest Podiatry, P.c. 5270 Alexander Rd, Dublin, VA 24084-3650 Ph: (540) 674-2444 |
News Archive
Marking the 10th anniversary of U.N. Security Council Resolution 1325 the first to recognize the importance of women's 'full involvement' in efforts to maintain and promote peace and security Secretary of State Hillary Clinton on Tuesday together with U.N. Secretary-General Ban Ki-moon and diplomats called for increased action to end sexual violence in war and increase women's involvement in peace-building efforts, the Associated Press/Forbes reports.
The Cardiovascular Cell Therapy Research Network (CCTRN), a nationwide U.S. network funded by the National Institutes of Health's (NIH) National Heart, Lung and Blood Institute (NHLBI) has selected the Minneapolis Heart Institute- (MHI) as one of its seven U.S. centers of excellence.
Small biotechnology companies developing new medical therapies and advanced biofuels need help attracting new capital, as investors have become especially risk averse. The Biotechnology Industry Organization (BIO) today conveyed support for the Small Business Early-Stage Investment Act of 2009, which would create a funding program at the Small Business Administration to stimulate growth in early-stage technology-based companies.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].
Adults with diabetes and multi-vessel coronary heart disease who underwent cardiac bypass surgery had better overall heart-related outcomes than those who underwent an artery-opening procedure to improve blood flow to the heart muscle, according to the results from an international study. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
› Verified 3 days ago
Sushila Lynn Kabadi, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5270 Alexander Rd, Dublin, VA 24084 Phone: 540-674-2444 Fax: 540-674-2462 |